Growth Metrics

Catalyst Pharmaceuticals (CPRX) Other Working Capital Changes (2016 - 2026)

Catalyst Pharmaceuticals filings provide 17 years of Other Working Capital Changes readings, the most recent being -$106000.0 for Q1 2026.

  • On a quarterly basis, Other Working Capital Changes fell 9.28% to -$106000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $168000.0, a 144.56% increase, with the full-year FY2024 number at $11124.0, up 103.29% from a year prior.
  • Other Working Capital Changes hit -$106000.0 in Q1 2026 for Catalyst Pharmaceuticals, down from $476000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $11.1 million in Q2 2024 to a low of -$7.6 million in Q4 2023.
  • Median Other Working Capital Changes over the past 5 years was -$89000.0 (2024), compared with a mean of $10058.8.
  • The widest YoY moves for Other Working Capital Changes: up 2625.12% in 2023, down 829.44% in 2023.
  • Catalyst Pharmaceuticals' Other Working Capital Changes stood at $1.0 million in 2022, then tumbled by 829.44% to -$7.6 million in 2023, then increased by 17.72% to -$6.2 million in 2024, then skyrocketed by 107.66% to $476000.0 in 2025, then crashed by 122.27% to -$106000.0 in 2026.
  • The last three reported values for Other Working Capital Changes were -$106000.0 (Q1 2026), $476000.0 (Q4 2025), and -$686000.0 (Q3 2025) per Business Quant data.